Switching from Fluvoxamine to Desvenlafaxine

Recommended Protocol

The American Academy of Child and Adolescent Psychiatry recommends initiating desvenlafaxine at 50 mg daily immediately after discontinuing fluvoxamine 75 mg without a washout period, while monitoring closely for serotonin syndrome in the first 24-48 hours 1, 2
Taper fluvoxamine gradually over 1-2 weeks before initiating desvenlafaxine to minimize discontinuation syndrome, as fluvoxamine is specifically associated with withdrawal symptoms including dizziness, fatigue, sensory disturbances, paresthesias, anxiety, and agitation 1, 3

Monitor intensively for serotonin syndrome symptoms in the first 24-48 hours after initiating desvenlafaxine, as combining two serotonergic drugs (even sequentially) carries elevated risk, and watch specifically for confusion, agitation, tremors, clonus, hyperreflexia, muscle rigidity, autonomic instability, and mental status changes 1, 2
The American Academy of Child and Adolescent Psychiatry advises that these symptoms require immediate medical attention if they develop 2

Fluvoxamine is a potent inhibitor of CYP1A2 and moderately inhibits CYP2C19, CYP2C9, CYP3A4, and CYP2D6, which can affect metabolism of numerous concurrent medications, and as fluvoxamine is discontinued, medications previously affected by these interactions may have increased clearance, potentially requiring dose adjustments 1

The American Academy of Child and Adolescent Psychiatry recommends not abruptly discontinuing fluvoxamine without tapering, as this dramatically increases risk of discontinuation syndrome 1, 3
Monitor for suicidal ideation during the transition period, as all antidepressants carry a boxed warning for increased suicidal thinking and behavior through age 24 years 3

Most adverse effects emerge within the first few weeks of treatment, according to the American Academy of Child and Adolescent Psychiatry 3